| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 225 | 2024 | 12241 | 7.340 |
Why?
|
| Insulin Resistance | 84 | 2023 | 3981 | 4.140 |
Why?
|
| Blood Glucose | 105 | 2024 | 6430 | 3.800 |
Why?
|
| Fasting | 47 | 2022 | 1610 | 3.190 |
Why?
|
| Insulin | 74 | 2023 | 6607 | 2.910 |
Why?
|
| Polymorphism, Single Nucleotide | 124 | 2024 | 16028 | 2.800 |
Why?
|
| Genome-Wide Association Study | 93 | 2024 | 12778 | 2.280 |
Why?
|
| Diabetes Mellitus | 56 | 2023 | 5891 | 2.230 |
Why?
|
| Cardiovascular Diseases | 88 | 2024 | 15649 | 1.970 |
Why?
|
| Adiponectin | 24 | 2019 | 1117 | 1.790 |
Why?
|
| Genetic Variation | 46 | 2022 | 6606 | 1.660 |
Why?
|
| Genetic Predisposition to Disease | 79 | 2024 | 18048 | 1.600 |
Why?
|
| Obesity | 72 | 2023 | 13084 | 1.570 |
Why?
|
| Genotype | 53 | 2023 | 13042 | 1.410 |
Why?
|
| Diabetic Angiopathies | 13 | 2020 | 806 | 1.400 |
Why?
|
| Body Mass Index | 75 | 2023 | 13052 | 1.290 |
Why?
|
| Hyperglycemia | 21 | 2023 | 1389 | 1.260 |
Why?
|
| Albuminuria | 20 | 2013 | 658 | 1.210 |
Why?
|
| Quantitative Trait Loci | 24 | 2021 | 2127 | 1.200 |
Why?
|
| Risk Factors | 193 | 2024 | 74962 | 1.200 |
Why?
|
| Middle Aged | 326 | 2024 | 223491 | 1.120 |
Why?
|
| Resistin | 10 | 2012 | 172 | 1.110 |
Why?
|
| Glucose Intolerance | 15 | 2023 | 579 | 1.100 |
Why?
|
| Prediabetic State | 11 | 2023 | 548 | 1.050 |
Why?
|
| Male | 348 | 2024 | 364902 | 0.940 |
Why?
|
| Female | 374 | 2024 | 397089 | 0.930 |
Why?
|
| Humans | 516 | 2024 | 768393 | 0.920 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2021 | 540 | 0.900 |
Why?
|
| Coronary Disease | 22 | 2023 | 5924 | 0.810 |
Why?
|
| Genome, Human | 18 | 2021 | 4450 | 0.810 |
Why?
|
| Adult | 227 | 2024 | 223640 | 0.800 |
Why?
|
| Intra-Abdominal Fat | 10 | 2014 | 624 | 0.800 |
Why?
|
| Aged | 191 | 2024 | 171562 | 0.790 |
Why?
|
| Diabetes Complications | 11 | 2024 | 1322 | 0.770 |
Why?
|
| Genetic Loci | 19 | 2022 | 2630 | 0.740 |
Why?
|
| Glucose | 17 | 2023 | 4352 | 0.730 |
Why?
|
| Multifactorial Inheritance | 10 | 2024 | 1421 | 0.710 |
Why?
|
| Relief Work | 1 | 2022 | 131 | 0.710 |
Why?
|
| Gene Frequency | 23 | 2019 | 3617 | 0.670 |
Why?
|
| Cholesterol, HDL | 19 | 2021 | 1820 | 0.670 |
Why?
|
| Coronary Artery Disease | 17 | 2024 | 6567 | 0.670 |
Why?
|
| Insulin, Long-Acting | 3 | 2014 | 59 | 0.660 |
Why?
|
| Proinsulin | 6 | 2023 | 135 | 0.660 |
Why?
|
| Hypoglycemic Agents | 17 | 2020 | 3108 | 0.640 |
Why?
|
| Metabolomics | 3 | 2022 | 1674 | 0.630 |
Why?
|
| Hypertension | 35 | 2020 | 8615 | 0.630 |
Why?
|
| Incidence | 59 | 2024 | 21544 | 0.620 |
Why?
|
| Primary Health Care | 13 | 2024 | 4748 | 0.620 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 8 | 2016 | 279 | 0.620 |
Why?
|
| Patient Compliance | 14 | 2009 | 2693 | 0.610 |
Why?
|
| Phenotype | 41 | 2024 | 16721 | 0.610 |
Why?
|
| Cohort Studies | 90 | 2024 | 41795 | 0.610 |
Why?
|
| Massachusetts | 39 | 2014 | 8902 | 0.600 |
Why?
|
| Weight Gain | 6 | 2013 | 2356 | 0.590 |
Why?
|
| Glucose Tolerance Test | 22 | 2023 | 1183 | 0.580 |
Why?
|
| Genetic Association Studies | 12 | 2022 | 2742 | 0.560 |
Why?
|
| Insulin-Secreting Cells | 7 | 2020 | 899 | 0.560 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2021 | 558 | 0.550 |
Why?
|
| Diet | 24 | 2023 | 8090 | 0.540 |
Why?
|
| Triglycerides | 22 | 2021 | 2465 | 0.540 |
Why?
|
| Polymorphism, Genetic | 15 | 2022 | 4250 | 0.520 |
Why?
|
| Adipose Tissue | 8 | 2019 | 3334 | 0.490 |
Why?
|
| Acculturation | 1 | 2016 | 179 | 0.490 |
Why?
|
| Heart Diseases | 11 | 2014 | 2819 | 0.490 |
Why?
|
| Models, Genetic | 11 | 2022 | 3442 | 0.490 |
Why?
|
| Atherosclerosis | 6 | 2023 | 3431 | 0.480 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 33 | 0.470 |
Why?
|
| Alleles | 26 | 2022 | 6892 | 0.470 |
Why?
|
| Prevalence | 36 | 2022 | 15872 | 0.460 |
Why?
|
| Genetic Counseling | 4 | 2012 | 634 | 0.460 |
Why?
|
| Chromosome Mapping | 12 | 2018 | 4622 | 0.460 |
Why?
|
| C-Reactive Protein | 20 | 2022 | 3857 | 0.460 |
Why?
|
| Hyperinsulinism | 6 | 2015 | 401 | 0.460 |
Why?
|
| Life Style | 19 | 2022 | 3929 | 0.440 |
Why?
|
| Refugees | 1 | 2022 | 612 | 0.440 |
Why?
|
| Outpatient Clinics, Hospital | 3 | 2004 | 395 | 0.440 |
Why?
|
| Subcutaneous Fat | 4 | 2013 | 403 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2014 | 411 | 0.430 |
Why?
|
| Health Literacy | 2 | 2016 | 468 | 0.430 |
Why?
|
| Dyslipidemias | 6 | 2021 | 873 | 0.430 |
Why?
|
| Smoking Cessation | 3 | 2016 | 2083 | 0.430 |
Why?
|
| Genetic Linkage | 5 | 2008 | 2342 | 0.430 |
Why?
|
| Adiposity | 9 | 2020 | 1895 | 0.430 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2018 | 4357 | 0.430 |
Why?
|
| Mendelian Randomization Analysis | 8 | 2022 | 1037 | 0.420 |
Why?
|
| American Heart Association | 9 | 2010 | 1051 | 0.420 |
Why?
|
| Meta-Analysis as Topic | 13 | 2021 | 1364 | 0.420 |
Why?
|
| Longitudinal Studies | 33 | 2024 | 14784 | 0.410 |
Why?
|
| Odds Ratio | 29 | 2020 | 9682 | 0.410 |
Why?
|
| Disease Management | 4 | 2020 | 2537 | 0.410 |
Why?
|
| Aging | 14 | 2022 | 8764 | 0.400 |
Why?
|
| Aged, 80 and over | 54 | 2022 | 59686 | 0.400 |
Why?
|
| Lipids | 14 | 2021 | 3344 | 0.390 |
Why?
|
| Choristoma | 1 | 2013 | 205 | 0.390 |
Why?
|
| Prospective Studies | 50 | 2023 | 54920 | 0.380 |
Why?
|
| Cross-Sectional Studies | 55 | 2022 | 26375 | 0.380 |
Why?
|
| Risk Assessment | 24 | 2024 | 24318 | 0.380 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2016 | 1943 | 0.370 |
Why?
|
| Genetic Testing | 6 | 2012 | 3587 | 0.370 |
Why?
|
| Diabetic Retinopathy | 6 | 2024 | 1299 | 0.370 |
Why?
|
| Case-Control Studies | 39 | 2024 | 22296 | 0.370 |
Why?
|
| Electronic Health Records | 6 | 2024 | 4875 | 0.360 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 572 | 0.350 |
Why?
|
| Prostatic Hyperplasia | 5 | 2002 | 523 | 0.350 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 137 | 0.350 |
Why?
|
| Hypoglycemia | 2 | 2015 | 894 | 0.350 |
Why?
|
| Sweetening Agents | 4 | 2017 | 290 | 0.340 |
Why?
|
| United States | 70 | 2024 | 73150 | 0.340 |
Why?
|
| Follow-Up Studies | 37 | 2018 | 39407 | 0.330 |
Why?
|
| Interleukin-6 | 10 | 2022 | 3230 | 0.330 |
Why?
|
| Linkage Disequilibrium | 12 | 2024 | 1998 | 0.330 |
Why?
|
| Proportional Hazards Models | 25 | 2019 | 12558 | 0.330 |
Why?
|
| Vitamin D | 5 | 2018 | 3310 | 0.320 |
Why?
|
| Attitude to Health | 2 | 2009 | 2025 | 0.320 |
Why?
|
| Blood Pressure | 22 | 2018 | 8541 | 0.310 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2009 | 348 | 0.310 |
Why?
|
| Predictive Value of Tests | 19 | 2021 | 15455 | 0.310 |
Why?
|
| Logistic Models | 27 | 2020 | 13323 | 0.310 |
Why?
|
| Sex Factors | 28 | 2024 | 10654 | 0.310 |
Why?
|
| Nutrition Surveys | 11 | 2022 | 1736 | 0.310 |
Why?
|
| Magnesium | 4 | 2013 | 816 | 0.300 |
Why?
|
| Inflammation | 19 | 2014 | 10863 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2008 | 640 | 0.300 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 7 | 2013 | 152 | 0.300 |
Why?
|
| Stroke | 15 | 2021 | 9742 | 0.290 |
Why?
|
| Evidence-Based Medicine | 6 | 2023 | 3707 | 0.290 |
Why?
|
| Vitamin D Deficiency | 2 | 2018 | 1389 | 0.290 |
Why?
|
| Creatinine | 11 | 2012 | 1915 | 0.290 |
Why?
|
| Health Behavior | 7 | 2012 | 2647 | 0.290 |
Why?
|
| Physicians, Family | 1 | 2009 | 349 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2008 | 350 | 0.280 |
Why?
|
| Multivariate Analysis | 30 | 2018 | 12092 | 0.280 |
Why?
|
| Risk | 20 | 2020 | 9636 | 0.280 |
Why?
|
| E-Selectin | 4 | 2005 | 578 | 0.280 |
Why?
|
| Waist-Hip Ratio | 7 | 2021 | 520 | 0.280 |
Why?
|
| Genomic Imprinting | 3 | 2020 | 324 | 0.280 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 325 | 0.280 |
Why?
|
| Linear Models | 16 | 2017 | 5878 | 0.270 |
Why?
|
| Postprandial Period | 2 | 2006 | 320 | 0.270 |
Why?
|
| Feeding Behavior | 11 | 2017 | 3203 | 0.270 |
Why?
|
| Socioeconomic Factors | 13 | 2022 | 7861 | 0.260 |
Why?
|
| HIV Infections | 16 | 2024 | 17575 | 0.260 |
Why?
|
| Cholesterol, LDL | 13 | 2022 | 2398 | 0.260 |
Why?
|
| Social Support | 1 | 2016 | 2191 | 0.260 |
Why?
|
| Dietary Fats | 5 | 2019 | 2003 | 0.260 |
Why?
|
| Oxidative Stress | 5 | 2014 | 3139 | 0.250 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 1260 | 0.250 |
Why?
|
| Genetic Heterogeneity | 2 | 2010 | 737 | 0.250 |
Why?
|
| Age Factors | 21 | 2017 | 18471 | 0.250 |
Why?
|
| Sarcopenia | 2 | 2022 | 376 | 0.250 |
Why?
|
| Islets of Langerhans | 5 | 2024 | 1350 | 0.250 |
Why?
|
| Yogurt | 3 | 2017 | 71 | 0.250 |
Why?
|
| Documentation | 2 | 2009 | 917 | 0.250 |
Why?
|
| Population Groups | 2 | 2019 | 208 | 0.240 |
Why?
|
| Food Supply | 4 | 2018 | 544 | 0.240 |
Why?
|
| Endothelium, Vascular | 8 | 2012 | 4427 | 0.240 |
Why?
|
| Body Size | 5 | 2020 | 463 | 0.240 |
Why?
|
| TCF Transcription Factors | 4 | 2010 | 138 | 0.240 |
Why?
|
| Adipokines | 3 | 2017 | 309 | 0.230 |
Why?
|
| Aorta, Abdominal | 3 | 2013 | 627 | 0.230 |
Why?
|
| Body Composition | 7 | 2022 | 2461 | 0.230 |
Why?
|
| Hemostasis | 4 | 2012 | 468 | 0.230 |
Why?
|
| Health Surveys | 11 | 2021 | 4056 | 0.230 |
Why?
|
| Lod Score | 4 | 2008 | 600 | 0.230 |
Why?
|
| Minisatellite Repeats | 1 | 2004 | 164 | 0.230 |
Why?
|
| Beverages | 3 | 2017 | 819 | 0.220 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2024 | 95 | 0.220 |
Why?
|
| Body Fat Distribution | 3 | 2022 | 246 | 0.220 |
Why?
|
| Information Systems | 1 | 2006 | 400 | 0.220 |
Why?
|
| Subcutaneous Fat, Abdominal | 3 | 2010 | 91 | 0.220 |
Why?
|
| Inflammation Mediators | 3 | 2009 | 1890 | 0.220 |
Why?
|
| Waist Circumference | 9 | 2015 | 935 | 0.220 |
Why?
|
| Family Health | 4 | 2016 | 1255 | 0.220 |
Why?
|
| Homeostasis | 11 | 2019 | 3349 | 0.210 |
Why?
|
| Cholesterol | 13 | 2017 | 2912 | 0.210 |
Why?
|
| Outpatients | 3 | 2021 | 1604 | 0.210 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2024 | 209 | 0.210 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2022 | 325 | 0.210 |
Why?
|
| Neoplasms | 7 | 2016 | 22385 | 0.210 |
Why?
|
| Overweight | 9 | 2013 | 2445 | 0.210 |
Why?
|
| Myocardial Infarction | 6 | 2024 | 11516 | 0.200 |
Why?
|
| Carbonated Beverages | 3 | 2016 | 210 | 0.200 |
Why?
|
| Poverty | 6 | 2021 | 2721 | 0.200 |
Why?
|
| Hyperlipidemias | 8 | 2010 | 773 | 0.200 |
Why?
|
| Hypercholesterolemia | 5 | 2010 | 1142 | 0.200 |
Why?
|
| DNA Methylation | 4 | 2023 | 4421 | 0.200 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2015 | 83 | 0.200 |
Why?
|
| Polypharmacy | 1 | 2004 | 307 | 0.200 |
Why?
|
| Self Care | 4 | 2008 | 797 | 0.200 |
Why?
|
| Dairy Products | 2 | 2017 | 490 | 0.200 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1794 | 0.190 |
Why?
|
| Metabolic Diseases | 3 | 2008 | 684 | 0.190 |
Why?
|
| Sickle Cell Trait | 1 | 2022 | 86 | 0.190 |
Why?
|
| Internet | 2 | 2005 | 3107 | 0.190 |
Why?
|
| Leptin | 3 | 2020 | 1597 | 0.190 |
Why?
|
| Income | 3 | 2020 | 1877 | 0.190 |
Why?
|
| Smoking | 19 | 2016 | 9111 | 0.190 |
Why?
|
| Antihypertensive Agents | 5 | 2008 | 2027 | 0.190 |
Why?
|
| Homocysteine | 3 | 2012 | 637 | 0.190 |
Why?
|
| Cluster Analysis | 4 | 2014 | 2728 | 0.190 |
Why?
|
| Glucose-6-Phosphatase | 3 | 2016 | 71 | 0.190 |
Why?
|
| Alanine Transaminase | 2 | 2022 | 605 | 0.190 |
Why?
|
| Molecular Epidemiology | 3 | 2019 | 473 | 0.190 |
Why?
|
| Drug Costs | 2 | 2006 | 1196 | 0.180 |
Why?
|
| Ankle Brachial Index | 2 | 2013 | 163 | 0.180 |
Why?
|
| Kidney Failure, Chronic | 6 | 2012 | 2491 | 0.180 |
Why?
|
| Microvascular Angina | 1 | 2000 | 14 | 0.180 |
Why?
|
| Genomics | 6 | 2023 | 5916 | 0.180 |
Why?
|
| Health Status Indicators | 1 | 2006 | 971 | 0.180 |
Why?
|
| Carbohydrates | 2 | 2016 | 389 | 0.180 |
Why?
|
| Educational Status | 5 | 2020 | 2518 | 0.180 |
Why?
|
| Molecular Sequence Annotation | 3 | 2021 | 525 | 0.180 |
Why?
|
| Insurance Claim Review | 1 | 2005 | 746 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2022 | 2296 | 0.180 |
Why?
|
| Aldosterone | 6 | 2010 | 881 | 0.170 |
Why?
|
| von Willebrand Factor | 3 | 2010 | 680 | 0.170 |
Why?
|
| Regression Analysis | 15 | 2018 | 6350 | 0.170 |
Why?
|
| Obesity, Abdominal | 3 | 2013 | 375 | 0.170 |
Why?
|
| Geriatrics | 2 | 2004 | 390 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 621 | 0.170 |
Why?
|
| Apolipoproteins E | 4 | 2005 | 1459 | 0.170 |
Why?
|
| Prostate-Specific Antigen | 3 | 2001 | 2487 | 0.170 |
Why?
|
| Area Under Curve | 4 | 2018 | 1642 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 1813 | 0.170 |
Why?
|
| Blood Chemical Analysis | 1 | 2001 | 436 | 0.170 |
Why?
|
| Developing Countries | 3 | 2021 | 2903 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2017 | 3252 | 0.170 |
Why?
|
| Confidence Intervals | 10 | 2013 | 2931 | 0.170 |
Why?
|
| Models, Statistical | 6 | 2021 | 5099 | 0.160 |
Why?
|
| Glycemic Index | 4 | 2015 | 400 | 0.160 |
Why?
|
| Genes, Mitochondrial | 1 | 2018 | 58 | 0.160 |
Why?
|
| Motivation | 5 | 2012 | 2029 | 0.160 |
Why?
|
| Pyrophosphatases | 2 | 2010 | 142 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 1614 | 0.160 |
Why?
|
| Urinary Retention | 1 | 1999 | 106 | 0.150 |
Why?
|
| Open Reading Frames | 1 | 2021 | 812 | 0.150 |
Why?
|
| Metabolome | 3 | 2016 | 1008 | 0.150 |
Why?
|
| Health Services | 2 | 2016 | 756 | 0.150 |
Why?
|
| ROC Curve | 5 | 2021 | 3623 | 0.150 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2010 | 205 | 0.150 |
Why?
|
| Abdominal Fat | 3 | 2010 | 221 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 5 | 2013 | 1004 | 0.150 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 11918 | 0.150 |
Why?
|
| Bayes Theorem | 3 | 2024 | 2353 | 0.150 |
Why?
|
| Monitoring, Immunologic | 1 | 1998 | 100 | 0.150 |
Why?
|
| Pedigree | 7 | 2020 | 4544 | 0.150 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2010 | 1751 | 0.150 |
Why?
|
| Health Maintenance Organizations | 5 | 2007 | 658 | 0.150 |
Why?
|
| Mexico | 4 | 2021 | 767 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 507 | 0.150 |
Why?
|
| Taurine | 1 | 2018 | 92 | 0.150 |
Why?
|
| Fathers | 1 | 2000 | 378 | 0.150 |
Why?
|
| Time Factors | 17 | 2018 | 40272 | 0.150 |
Why?
|
| Risk Reduction Behavior | 3 | 2011 | 1118 | 0.140 |
Why?
|
| Weight Loss | 7 | 2022 | 2713 | 0.140 |
Why?
|
| Blood Coagulation Factors | 1 | 2000 | 366 | 0.140 |
Why?
|
| Metabolism | 1 | 2018 | 193 | 0.140 |
Why?
|
| Receptors, Leptin | 2 | 2009 | 350 | 0.140 |
Why?
|
| Insurance, Health | 3 | 2010 | 2518 | 0.140 |
Why?
|
| Pericardium | 2 | 2014 | 679 | 0.140 |
Why?
|
| Diet, Mediterranean | 3 | 2009 | 744 | 0.140 |
Why?
|
| Severity of Illness Index | 7 | 2021 | 15939 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 3231 | 0.140 |
Why?
|
| Young Adult | 23 | 2022 | 60049 | 0.140 |
Why?
|
| Neck | 2 | 2013 | 736 | 0.140 |
Why?
|
| Boston | 8 | 2018 | 9371 | 0.140 |
Why?
|
| Apolipoprotein B-100 | 2 | 2015 | 157 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 520 | 0.140 |
Why?
|
| Computational Biology | 5 | 2021 | 3543 | 0.130 |
Why?
|
| Physician-Patient Relations | 3 | 2011 | 3267 | 0.130 |
Why?
|
| Phenylalanine | 1 | 2018 | 368 | 0.130 |
Why?
|
| Hospitalization | 6 | 2022 | 10844 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 7 | 2010 | 2226 | 0.130 |
Why?
|
| Haplotypes | 4 | 2021 | 2724 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
| Body Weight | 9 | 2014 | 4629 | 0.130 |
Why?
|
| Patient Selection | 4 | 2009 | 4266 | 0.130 |
Why?
|
| Dietary Sucrose | 3 | 2014 | 243 | 0.130 |
Why?
|
| Fatty Liver | 2 | 2014 | 807 | 0.130 |
Why?
|
| Calcinosis | 3 | 2013 | 1481 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2016 | 294 | 0.130 |
Why?
|
| Reference Values | 9 | 2017 | 4941 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2016 | 1163 | 0.130 |
Why?
|
| Algorithms | 8 | 2024 | 14154 | 0.130 |
Why?
|
| Epigenesis, Genetic | 5 | 2023 | 3827 | 0.120 |
Why?
|
| Health Facilities | 1 | 2020 | 577 | 0.120 |
Why?
|
| Chemokines, CC | 1 | 2016 | 286 | 0.120 |
Why?
|
| Meat Products | 1 | 2015 | 97 | 0.120 |
Why?
|
| Kidney Diseases | 3 | 2013 | 2103 | 0.120 |
Why?
|
| Genetic Markers | 5 | 2023 | 2604 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 798 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2020 | 2437 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3794 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 2337 | 0.120 |
Why?
|
| Adult Children | 3 | 2013 | 104 | 0.120 |
Why?
|
| Health Expenditures | 2 | 2017 | 2395 | 0.120 |
Why?
|
| Tryptophan | 2 | 2021 | 482 | 0.120 |
Why?
|
| Least-Squares Analysis | 2 | 2016 | 368 | 0.120 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 250 | 0.120 |
Why?
|
| Glycine | 1 | 2018 | 672 | 0.120 |
Why?
|
| Meat | 2 | 2015 | 588 | 0.120 |
Why?
|
| Advisory Committees | 2 | 2009 | 797 | 0.120 |
Why?
|
| Milk | 2 | 2017 | 443 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2024 | 3440 | 0.120 |
Why?
|
| Genome | 1 | 2022 | 1747 | 0.120 |
Why?
|
| Disease Progression | 7 | 2024 | 13646 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2016 | 415 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2019 | 540 | 0.110 |
Why?
|
| Syntaxin 1 | 1 | 2014 | 29 | 0.110 |
Why?
|
| Guideline Adherence | 3 | 2017 | 2240 | 0.110 |
Why?
|
| R-SNARE Proteins | 1 | 2014 | 73 | 0.110 |
Why?
|
| Prognosis | 13 | 2024 | 30022 | 0.110 |
Why?
|
| Atrial Function | 1 | 2014 | 99 | 0.110 |
Why?
|
| Nuclear Family | 2 | 2007 | 311 | 0.110 |
Why?
|
| Transcription Factors | 7 | 2023 | 12166 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1088 | 0.110 |
Why?
|
| Monitoring, Physiologic | 2 | 2020 | 1795 | 0.110 |
Why?
|
| Spouses | 1 | 2016 | 286 | 0.110 |
Why?
|
| Introns | 1 | 2016 | 968 | 0.110 |
Why?
|
| Metformin | 4 | 2011 | 911 | 0.110 |
Why?
|
| Adolescent | 23 | 2021 | 89184 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 871 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 44 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 3 | 2011 | 2181 | 0.110 |
Why?
|
| Flavonols | 1 | 2013 | 85 | 0.110 |
Why?
|
| Homozygote | 3 | 2015 | 1779 | 0.110 |
Why?
|
| Stress, Psychological | 3 | 2008 | 4543 | 0.110 |
Why?
|
| Nutrition Policy | 2 | 2007 | 467 | 0.110 |
Why?
|
| Databases, Genetic | 3 | 2021 | 1748 | 0.100 |
Why?
|
| Genetic Pleiotropy | 1 | 2014 | 181 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 2013 | 2819 | 0.100 |
Why?
|
| Chronic Disease | 4 | 2024 | 9379 | 0.100 |
Why?
|
| Nutrition Assessment | 2 | 2014 | 740 | 0.100 |
Why?
|
| Intensive Care Units | 3 | 2021 | 3801 | 0.100 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 5512 | 0.100 |
Why?
|
| Italy | 4 | 2011 | 854 | 0.100 |
Why?
|
| Integrin alpha1 | 1 | 2012 | 13 | 0.100 |
Why?
|
| Lipoproteins | 3 | 2003 | 880 | 0.100 |
Why?
|
| Body Height | 3 | 2015 | 1568 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2004 | 2529 | 0.100 |
Why?
|
| Comorbidity | 9 | 2020 | 10588 | 0.100 |
Why?
|
| Food | 1 | 2017 | 768 | 0.100 |
Why?
|
| Europe | 5 | 2020 | 3439 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2022 | 1593 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1548 | 0.100 |
Why?
|
| Apolipoprotein C-I | 1 | 2011 | 14 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2003 | 277 | 0.100 |
Why?
|
| Energy Intake | 8 | 2014 | 2145 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 101 | 0.100 |
Why?
|
| Causality | 4 | 2022 | 1255 | 0.100 |
Why?
|
| Vitamin K 1 | 2 | 2009 | 47 | 0.100 |
Why?
|
| Dietary Carbohydrates | 2 | 2009 | 896 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 262 | 0.100 |
Why?
|
| High Mobility Group Proteins | 1 | 2012 | 179 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 873 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1197 | 0.100 |
Why?
|
| Bone Density | 3 | 2014 | 3559 | 0.100 |
Why?
|
| Anorexia Nervosa | 1 | 2021 | 1364 | 0.090 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 7955 | 0.090 |
Why?
|
| Heart Failure | 3 | 2013 | 11858 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2012 | 487 | 0.090 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 131 | 0.090 |
Why?
|
| Exercise | 7 | 2012 | 5946 | 0.090 |
Why?
|
| Texas | 2 | 2003 | 409 | 0.090 |
Why?
|
| Trace Elements | 1 | 2013 | 193 | 0.090 |
Why?
|
| RANK Ligand | 1 | 2013 | 321 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 878 | 0.090 |
Why?
|
| Epigenomics | 3 | 2024 | 959 | 0.090 |
Why?
|
| Retrospective Studies | 23 | 2023 | 81801 | 0.090 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 1901 | 0.090 |
Why?
|
| Phosphate Transport Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Menopause, Premature | 1 | 1992 | 124 | 0.090 |
Why?
|
| Cotinine | 1 | 2011 | 206 | 0.090 |
Why?
|
| Laminin | 1 | 2012 | 406 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2014 | 624 | 0.090 |
Why?
|
| Health Care Costs | 2 | 2018 | 3267 | 0.090 |
Why?
|
| Costs and Cost Analysis | 2 | 2006 | 1669 | 0.090 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 52 | 0.090 |
Why?
|
| Data Collection | 4 | 2010 | 3324 | 0.090 |
Why?
|
| Diabetic Nephropathies | 3 | 2024 | 975 | 0.090 |
Why?
|
| Endpoint Determination | 1 | 2013 | 594 | 0.090 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2005 | 692 | 0.090 |
Why?
|
| Mothers | 1 | 2000 | 2211 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1943 | 0.080 |
Why?
|
| Liver | 5 | 2021 | 7574 | 0.080 |
Why?
|
| Antipsychotic Agents | 1 | 2023 | 3080 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 4414 | 0.080 |
Why?
|
| Factor VII | 1 | 2010 | 139 | 0.080 |
Why?
|
| Anthropometry | 4 | 2018 | 1343 | 0.080 |
Why?
|
| Speech Recognition Software | 1 | 2010 | 74 | 0.080 |
Why?
|
| Calcification, Physiologic | 1 | 2010 | 171 | 0.080 |
Why?
|
| Lipodystrophy | 2 | 2001 | 145 | 0.080 |
Why?
|
| Sex Characteristics | 7 | 2021 | 2660 | 0.080 |
Why?
|
| Atrial Function, Left | 1 | 2011 | 188 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1409 | 0.080 |
Why?
|
| Dietary Supplements | 3 | 2013 | 3443 | 0.080 |
Why?
|
| Osteoporosis | 3 | 2014 | 1606 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 1368 | 0.080 |
Why?
|
| Age of Onset | 4 | 2013 | 3345 | 0.080 |
Why?
|
| Depression | 5 | 2008 | 8241 | 0.080 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2008 | 360 | 0.080 |
Why?
|
| Sample Size | 3 | 2021 | 848 | 0.080 |
Why?
|
| Receptors, Cannabinoid | 1 | 2009 | 43 | 0.080 |
Why?
|
| Ambulatory Care | 4 | 2021 | 2784 | 0.080 |
Why?
|
| Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
| Lipase | 2 | 2022 | 321 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1753 | 0.080 |
Why?
|
| Aorta, Thoracic | 2 | 2012 | 1112 | 0.080 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 8747 | 0.080 |
Why?
|
| Osteocalcin | 1 | 2009 | 277 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2019 | 6277 | 0.080 |
Why?
|
| Hip | 1 | 2010 | 255 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2011 | 1398 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 326 | 0.080 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 1056 | 0.080 |
Why?
|
| Medicine | 2 | 2009 | 948 | 0.080 |
Why?
|
| Heart Conduction System | 1 | 2014 | 1009 | 0.080 |
Why?
|
| Community-Institutional Relations | 1 | 2010 | 208 | 0.080 |
Why?
|
| Actinin | 2 | 1986 | 165 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2460 | 0.080 |
Why?
|
| Social Class | 4 | 2020 | 2009 | 0.070 |
Why?
|
| Amidohydrolases | 1 | 2009 | 160 | 0.070 |
Why?
|
| Intermittent Claudication | 1 | 2010 | 305 | 0.070 |
Why?
|
| Communication | 3 | 2024 | 3912 | 0.070 |
Why?
|
| Gene Dosage | 2 | 2010 | 1221 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2013 | 960 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 4775 | 0.070 |
Why?
|
| Interleukin-18 | 1 | 2009 | 251 | 0.070 |
Why?
|
| Factor VIII | 1 | 2010 | 349 | 0.070 |
Why?
|
| Dietary Fiber | 3 | 2006 | 767 | 0.070 |
Why?
|
| Patients | 2 | 2009 | 909 | 0.070 |
Why?
|
| Environment | 2 | 2011 | 1124 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2010 | 489 | 0.070 |
Why?
|
| Professional Practice | 1 | 2009 | 314 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 2972 | 0.070 |
Why?
|
| Sensitivity and Specificity | 6 | 2021 | 14737 | 0.070 |
Why?
|
| Privacy | 1 | 2009 | 233 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2005 | 1658 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 677 | 0.070 |
Why?
|
| Dinoprost | 1 | 2007 | 139 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 864 | 0.070 |
Why?
|
| Viral Load | 3 | 2012 | 3398 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2024 | 3587 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 923 | 0.070 |
Why?
|
| Motor Activity | 3 | 2012 | 2720 | 0.070 |
Why?
|
| Probability | 3 | 2013 | 2482 | 0.070 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 371 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2011 | 828 | 0.070 |
Why?
|
| Urban Population | 2 | 2012 | 2045 | 0.070 |
Why?
|
| Alcohol Drinking | 6 | 2013 | 4049 | 0.070 |
Why?
|
| Phorbols | 1 | 1986 | 44 | 0.070 |
Why?
|
| Diet Surveys | 5 | 2012 | 1160 | 0.070 |
Why?
|
| Hyperemia | 1 | 2008 | 224 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2012 | 877 | 0.070 |
Why?
|
| Telephone | 1 | 2010 | 630 | 0.070 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 1416 | 0.070 |
Why?
|
| Informatics | 1 | 2006 | 71 | 0.070 |
Why?
|
| Ghrelin | 1 | 2008 | 251 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2005 | 1133 | 0.070 |
Why?
|
| Anti-HIV Agents | 4 | 2012 | 4571 | 0.070 |
Why?
|
| Baltimore | 2 | 2004 | 234 | 0.070 |
Why?
|
| Sodium | 3 | 2006 | 1594 | 0.070 |
Why?
|
| Iron | 2 | 2005 | 1814 | 0.070 |
Why?
|
| Brain Ischemia | 2 | 2011 | 3008 | 0.060 |
Why?
|
| Brachial Artery | 1 | 2008 | 373 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2023 | 5126 | 0.060 |
Why?
|
| Membrane Proteins | 4 | 2022 | 7880 | 0.060 |
Why?
|
| Vitamin K | 1 | 2008 | 314 | 0.060 |
Why?
|
| Serum Albumin | 1 | 2009 | 676 | 0.060 |
Why?
|
| Models, Biological | 7 | 2013 | 9493 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7453 | 0.060 |
Why?
|
| Homeodomain Proteins | 4 | 2023 | 2429 | 0.060 |
Why?
|
| Molecular Weight | 3 | 2016 | 2172 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 274 | 0.060 |
Why?
|
| Chromans | 1 | 2005 | 117 | 0.060 |
Why?
|
| Cognition | 2 | 2015 | 7075 | 0.060 |
Why?
|
| Fruit | 2 | 2009 | 1164 | 0.060 |
Why?
|
| Drug Prescriptions | 2 | 2005 | 1673 | 0.060 |
Why?
|
| Body Constitution | 4 | 2004 | 273 | 0.060 |
Why?
|
| Mitochondria | 1 | 2018 | 3675 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2007 | 295 | 0.060 |
Why?
|
| Lisinopril | 1 | 2005 | 60 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2009 | 683 | 0.060 |
Why?
|
| Administration, Oral | 3 | 2009 | 4039 | 0.060 |
Why?
|
| Hydrochlorothiazide | 1 | 2005 | 95 | 0.060 |
Why?
|
| Atenolol | 1 | 2005 | 99 | 0.060 |
Why?
|
| Animals | 14 | 2019 | 169337 | 0.060 |
Why?
|
| Genetics, Population | 3 | 2021 | 942 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 299 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1986 | 826 | 0.060 |
Why?
|
| Retreatment | 1 | 2006 | 600 | 0.060 |
Why?
|
| Health Status | 4 | 2018 | 4094 | 0.060 |
Why?
|
| Natriuresis | 1 | 2004 | 105 | 0.060 |
Why?
|
| England | 2 | 2019 | 532 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2004 | 856 | 0.060 |
Why?
|
| International Classification of Diseases | 2 | 2024 | 924 | 0.060 |
Why?
|
| Adipocytes | 2 | 2024 | 1200 | 0.060 |
Why?
|
| Prostatic Neoplasms | 2 | 1998 | 11221 | 0.060 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 3941 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2004 | 107 | 0.060 |
Why?
|
| Quality of Life | 1 | 2006 | 13503 | 0.060 |
Why?
|
| Fractures, Ununited | 1 | 2006 | 176 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6856 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 20224 | 0.060 |
Why?
|
| Atrial Fibrillation | 3 | 2014 | 5168 | 0.060 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2007 | 475 | 0.060 |
Why?
|
| Air Pollution | 1 | 2017 | 2363 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 2007 | 376 | 0.060 |
Why?
|
| Academic Medical Centers | 2 | 2005 | 2783 | 0.060 |
Why?
|
| Trans Fatty Acids | 1 | 2005 | 155 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2018 | 2281 | 0.060 |
Why?
|
| Kidney | 4 | 2022 | 7064 | 0.060 |
Why?
|
| Puberty | 1 | 2007 | 502 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2017 | 2900 | 0.050 |
Why?
|
| Vasodilation | 1 | 2008 | 968 | 0.050 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 23 | 0.050 |
Why?
|
| Child | 12 | 2024 | 80891 | 0.050 |
Why?
|
| Population Surveillance | 2 | 2011 | 2598 | 0.050 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 848 | 0.050 |
Why?
|
| Insulysin | 1 | 2003 | 49 | 0.050 |
Why?
|
| Renin | 3 | 2010 | 648 | 0.050 |
Why?
|
| Advance Care Planning | 1 | 2011 | 698 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2012 | 1177 | 0.050 |
Why?
|
| Likelihood Functions | 2 | 2016 | 993 | 0.050 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2016 | 104 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 1281 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 2 | 2018 | 1794 | 0.050 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2004 | 353 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 79 | 0.050 |
Why?
|
| Cystatin C | 3 | 2010 | 272 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2003 | 88 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2011 | 1161 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2005 | 453 | 0.050 |
Why?
|
| Finland | 2 | 2017 | 609 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2014 | 2653 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2016 | 2596 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 429 | 0.050 |
Why?
|
| Perception | 1 | 2009 | 1205 | 0.050 |
Why?
|
| Endothelium | 1 | 2005 | 768 | 0.050 |
Why?
|
| Tibial Fractures | 1 | 2006 | 276 | 0.050 |
Why?
|
| Syndrome | 2 | 2000 | 3275 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 2 | 2012 | 941 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 4 | 2008 | 5801 | 0.050 |
Why?
|
| DNA | 3 | 2013 | 7211 | 0.050 |
Why?
|
| Abdomen | 3 | 2020 | 1136 | 0.050 |
Why?
|
| Fats | 1 | 2003 | 99 | 0.050 |
Why?
|
| Registries | 6 | 2013 | 8379 | 0.050 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2005 | 348 | 0.050 |
Why?
|
| Ferritins | 2 | 2022 | 600 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 462 | 0.050 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9510 | 0.050 |
Why?
|
| Caffeine | 2 | 2007 | 702 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2005 | 569 | 0.050 |
Why?
|
| Quality of Health Care | 3 | 2006 | 4339 | 0.050 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 248 | 0.050 |
Why?
|
| Alanine | 2 | 2003 | 613 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 861 | 0.050 |
Why?
|
| Treatment Outcome | 9 | 2022 | 65379 | 0.050 |
Why?
|
| Health Services Research | 3 | 2004 | 1817 | 0.050 |
Why?
|
| Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1901 | 0.050 |
Why?
|
| Education, Continuing | 1 | 2002 | 115 | 0.050 |
Why?
|
| Apolipoproteins C | 1 | 2001 | 59 | 0.050 |
Why?
|
| Prostatitis | 1 | 2002 | 102 | 0.050 |
Why?
|
| Antidepressive Agents | 2 | 2004 | 2913 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2010 | 10117 | 0.050 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 1883 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 1903 | 0.050 |
Why?
|
| Pregnancy | 4 | 2023 | 30200 | 0.050 |
Why?
|
| Goals | 1 | 2006 | 716 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2020 | 2911 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2006 | 749 | 0.050 |
Why?
|
| Lactase | 1 | 2021 | 72 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2013 | 174 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
| Family Practice | 1 | 2004 | 511 | 0.050 |
Why?
|
| Hyperaldosteronism | 1 | 2004 | 250 | 0.050 |
Why?
|
| Blood Sedimentation | 1 | 2022 | 235 | 0.050 |
Why?
|
| Pharmacists | 1 | 2003 | 261 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 4713 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2008 | 1959 | 0.040 |
Why?
|
| Lysophospholipase | 1 | 2020 | 66 | 0.040 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2020 | 58 | 0.040 |
Why?
|
| Kynurenine | 1 | 2021 | 142 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 1986 | 1165 | 0.040 |
Why?
|
| Isoelectric Focusing | 1 | 2000 | 149 | 0.040 |
Why?
|
| Organ Size | 3 | 2012 | 2268 | 0.040 |
Why?
|
| Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2012 | 2059 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.040 |
Why?
|
| Blood Flow Velocity | 3 | 2009 | 1376 | 0.040 |
Why?
|
| Telomere | 1 | 2006 | 943 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2021 | 8075 | 0.040 |
Why?
|
| Radiography | 4 | 2014 | 6993 | 0.040 |
Why?
|
| Hospitals, General | 2 | 2020 | 807 | 0.040 |
Why?
|
| California | 1 | 2024 | 1443 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2012 | 2062 | 0.040 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 3922 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2011 | 4047 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 267 | 0.040 |
Why?
|
| Eating | 2 | 2023 | 1541 | 0.040 |
Why?
|
| Hypolipidemic Agents | 2 | 2005 | 609 | 0.040 |
Why?
|
| Research Design | 2 | 2016 | 6210 | 0.040 |
Why?
|
| Treatment Refusal | 1 | 2003 | 432 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3813 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2022 | 425 | 0.040 |
Why?
|
| Mortality | 2 | 2009 | 2917 | 0.040 |
Why?
|
| Indians, North American | 2 | 2013 | 354 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 784 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2012 | 6541 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 1280 | 0.040 |
Why?
|
| Blood Viscosity | 1 | 2000 | 125 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 384 | 0.040 |
Why?
|
| Gene Expression | 3 | 2021 | 7598 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 2000 | 201 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2003 | 469 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 7445 | 0.040 |
Why?
|
| Environmental Exposure | 2 | 2014 | 4528 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 1362 | 0.040 |
Why?
|
| Specialization | 1 | 2004 | 781 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 1517 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 603 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 1440 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2000 | 331 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2001 | 527 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 303 | 0.040 |
Why?
|
| Coffee | 1 | 1983 | 598 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2020 | 320 | 0.040 |
Why?
|
| Bangladesh | 1 | 2020 | 741 | 0.040 |
Why?
|
| Kidney Function Tests | 2 | 2010 | 681 | 0.040 |
Why?
|
| Leukocytes | 1 | 2006 | 2030 | 0.040 |
Why?
|
| rho-Associated Kinases | 1 | 2020 | 286 | 0.040 |
Why?
|
| Cystatins | 2 | 2008 | 55 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2001 | 678 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 833 | 0.040 |
Why?
|
| Butter | 1 | 2017 | 22 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3953 | 0.040 |
Why?
|
| Heterozygote | 2 | 2021 | 2791 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2022 | 1605 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2017 | 129 | 0.040 |
Why?
|
| Cheese | 1 | 2017 | 39 | 0.040 |
Why?
|
| Osmolar Concentration | 2 | 2012 | 657 | 0.040 |
Why?
|
| Age Distribution | 2 | 2018 | 2877 | 0.040 |
Why?
|
| Prehypertension | 1 | 2018 | 63 | 0.040 |
Why?
|
| Physicians, Primary Care | 1 | 2024 | 623 | 0.040 |
Why?
|
| Health Resources | 1 | 2004 | 950 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2011 | 10377 | 0.040 |
Why?
|
| Stem Cells | 1 | 2010 | 3539 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2003 | 1191 | 0.040 |
Why?
|
| Parents | 1 | 2011 | 3596 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2007 | 1421 | 0.030 |
Why?
|
| Nurses | 2 | 2004 | 2494 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2021 | 1229 | 0.030 |
Why?
|
| Sulfates | 1 | 2017 | 379 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2006 | 2363 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3610 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2008 | 3125 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 42 | 0.030 |
Why?
|
| Health Education | 1 | 2003 | 1057 | 0.030 |
Why?
|
| Echocardiography | 2 | 2011 | 5044 | 0.030 |
Why?
|
| Epidemiologic Factors | 1 | 1996 | 36 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2010 | 2812 | 0.030 |
Why?
|
| China | 2 | 2013 | 2395 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2016 | 49 | 0.030 |
Why?
|
| Family | 2 | 2004 | 3208 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 1752 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Soot | 1 | 2017 | 221 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2016 | 108 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2022 | 1532 | 0.030 |
Why?
|
| Community Health Services | 2 | 2011 | 659 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2017 | 361 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2016 | 93 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 50 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2017 | 42650 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2012 | 20765 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 2663 | 0.030 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 2006 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2008 | 3736 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2016 | 190 | 0.030 |
Why?
|
| Colon | 1 | 2023 | 1805 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2022 | 1342 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 138 | 0.030 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Inpatients | 1 | 2007 | 2570 | 0.030 |
Why?
|
| Survival Rate | 3 | 2018 | 12870 | 0.030 |
Why?
|
| Demography | 2 | 2013 | 1642 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 182 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2015 | 90 | 0.030 |
Why?
|
| Immunoassay | 1 | 1998 | 745 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2022 | 3064 | 0.030 |
Why?
|
| Infant | 4 | 2022 | 36510 | 0.030 |
Why?
|
| CpG Islands | 1 | 2019 | 1209 | 0.030 |
Why?
|
| Binding Sites | 2 | 2015 | 6017 | 0.030 |
Why?
|
| Acute Disease | 2 | 2009 | 7242 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2001 | 972 | 0.030 |
Why?
|
| Folic Acid | 1 | 2001 | 1336 | 0.030 |
Why?
|
| Cause of Death | 2 | 2016 | 3728 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 382 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 589 | 0.030 |
Why?
|
| Hypertriglyceridemia | 2 | 2007 | 293 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2058 | 0.030 |
Why?
|
| Ozone | 1 | 2017 | 490 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 2004 | 3838 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12805 | 0.030 |
Why?
|
| Housing | 2 | 2017 | 680 | 0.030 |
Why?
|
| Brain | 3 | 2012 | 27454 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 646 | 0.030 |
Why?
|
| Residence Characteristics | 2 | 2017 | 2122 | 0.030 |
Why?
|
| Alpha-Globulins | 1 | 2013 | 26 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3212 | 0.030 |
Why?
|
| Proteins | 2 | 2010 | 6006 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 93 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1962 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 127 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 2014 | 2087 | 0.030 |
Why?
|
| Mucin-3 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Menopause | 3 | 2006 | 1653 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 855 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2017 | 656 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 937 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 3955 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 710 | 0.030 |
Why?
|
| Cell Line | 3 | 2013 | 15597 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 792 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1303 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2533 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 10776 | 0.020 |
Why?
|
| Treatment Failure | 2 | 2010 | 2663 | 0.020 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 172 | 0.020 |
Why?
|
| Chromatin | 1 | 2024 | 2968 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2012 | 97 | 0.020 |
Why?
|
| Counseling | 1 | 2000 | 1553 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2890 | 0.020 |
Why?
|
| Random Allocation | 1 | 1996 | 2397 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 139 | 0.020 |
Why?
|
| Social Marketing | 1 | 2011 | 52 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 2961 | 0.020 |
Why?
|
| Vegetables | 2 | 2009 | 1198 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 1992 | 132 | 0.020 |
Why?
|
| Diet Records | 1 | 2013 | 426 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 643 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 298 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2012 | 164 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 1463 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2011 | 142 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Guidelines as Topic | 2 | 2007 | 1397 | 0.020 |
Why?
|
| Exercise Test | 1 | 2018 | 2186 | 0.020 |
Why?
|
| Vitamins | 2 | 2009 | 1637 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5404 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 708 | 0.020 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2593 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 318 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1983 | 2257 | 0.020 |
Why?
|
| Bacteria | 1 | 2021 | 2221 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2011 | 171 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3438 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2014 | 682 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1820 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 329 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2017 | 1187 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1016 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2008 | 984 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 115 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2013 | 648 | 0.020 |
Why?
|
| Length of Stay | 1 | 2004 | 6519 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 390 | 0.020 |
Why?
|
| Connecticut | 4 | 1983 | 365 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2021 | 1731 | 0.020 |
Why?
|
| Organizations, Nonprofit | 1 | 2010 | 105 | 0.020 |
Why?
|
| Reminder Systems | 1 | 2012 | 387 | 0.020 |
Why?
|
| Endonucleases | 1 | 2012 | 371 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1078 | 0.020 |
Why?
|
| Skinfold Thickness | 2 | 1971 | 164 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4819 | 0.020 |
Why?
|
| Software | 1 | 2003 | 4453 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3612 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 100 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5313 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2721 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3579 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 442 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1824 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3906 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2011 | 838 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 812 | 0.020 |
Why?
|
| Metagenomics | 1 | 2012 | 475 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2009 | 320 | 0.020 |
Why?
|
| Physicians | 2 | 2003 | 4614 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4936 | 0.020 |
Why?
|
| Hormones | 1 | 2012 | 870 | 0.020 |
Why?
|
| Femur | 1 | 2014 | 1311 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 2012 | 649 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1085 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1992 | 555 | 0.020 |
Why?
|
| Mutation | 3 | 2023 | 30228 | 0.020 |
Why?
|
| Mice | 4 | 2019 | 82017 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4120 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2755 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2006 | 6987 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 454 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2014 | 6409 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1503 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 779 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1141 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2011 | 776 | 0.020 |
Why?
|
| Spine | 1 | 2014 | 1141 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 962 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2009 | 223 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 4981 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3587 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Sucrose | 1 | 2007 | 159 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5367 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2012 | 1186 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2007 | 248 | 0.020 |
Why?
|
| Veterans | 1 | 2020 | 2671 | 0.020 |
Why?
|
| Osteoprotegerin | 1 | 2007 | 179 | 0.020 |
Why?
|
| Epidemiologic Methods | 2 | 2009 | 1337 | 0.020 |
Why?
|
| Vinculin | 1 | 1986 | 59 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1319 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 5764 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9614 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2017 | 2609 | 0.020 |
Why?
|
| Thorax | 1 | 2009 | 559 | 0.020 |
Why?
|
| Rhodamines | 1 | 1986 | 178 | 0.020 |
Why?
|
| Manometry | 1 | 2008 | 459 | 0.020 |
Why?
|
| Albumins | 1 | 2008 | 577 | 0.020 |
Why?
|
| Vulvar Neoplasms | 2 | 1958 | 266 | 0.020 |
Why?
|
| HIV | 1 | 2012 | 1596 | 0.020 |
Why?
|
| Microinjections | 1 | 1986 | 323 | 0.020 |
Why?
|
| Calcium | 2 | 2009 | 5794 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 1008 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2009 | 829 | 0.020 |
Why?
|
| Siblings | 1 | 2009 | 829 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2009 | 943 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1988 | 379 | 0.010 |
Why?
|
| Glycerides | 1 | 1964 | 67 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2014 | 4142 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1539 | 0.010 |
Why?
|
| Cholecalciferol | 1 | 2009 | 557 | 0.010 |
Why?
|
| Heart | 2 | 2016 | 4449 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2489 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 1976 | 1946 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1992 | 1386 | 0.010 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2005 | 167 | 0.010 |
Why?
|
| Chickens | 1 | 1986 | 845 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2012 | 1627 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2856 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2007 | 834 | 0.010 |
Why?
|
| RNA Interference | 1 | 2012 | 2836 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2011 | 941 | 0.010 |
Why?
|
| Vasculitis | 1 | 2008 | 524 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1196 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14481 | 0.010 |
Why?
|
| Morbidity | 1 | 2009 | 1758 | 0.010 |
Why?
|
| Pinocytosis | 1 | 1983 | 63 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1742 | 0.010 |
Why?
|
| Emigrants and Immigrants | 1 | 2010 | 549 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 2005 | 386 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4291 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1986 | 564 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 544 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2003 | 85 | 0.010 |
Why?
|
| Diuretics | 1 | 2006 | 612 | 0.010 |
Why?
|
| Reproduction | 1 | 1988 | 646 | 0.010 |
Why?
|
| Abdominal Wall | 1 | 1964 | 167 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2003 | 123 | 0.010 |
Why?
|
| Arteries | 1 | 2008 | 1126 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2595 | 0.010 |
Why?
|
| Hemoglobinometry | 1 | 2002 | 35 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1988 | 708 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3712 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12422 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2004 | 300 | 0.010 |
Why?
|
| Myocardium | 2 | 1985 | 4788 | 0.010 |
Why?
|
| Forearm | 1 | 1964 | 428 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1986 | 930 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 455 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4537 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 2014 | 19022 | 0.010 |
Why?
|
| Iron Overload | 1 | 2004 | 246 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 588 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 505 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2007 | 904 | 0.010 |
Why?
|
| Peptides | 1 | 2013 | 4353 | 0.010 |
Why?
|
| Medical Records | 1 | 2007 | 1412 | 0.010 |
Why?
|
| Fishes | 1 | 2004 | 606 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2046 | 0.010 |
Why?
|
| Minority Groups | 1 | 2008 | 1215 | 0.010 |
Why?
|
| Patient Participation | 1 | 2010 | 1448 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1985 | 1176 | 0.010 |
Why?
|
| Threonine | 1 | 2001 | 274 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2004 | 6001 | 0.010 |
Why?
|
| Bulimia | 1 | 2002 | 405 | 0.010 |
Why?
|
| Delivery of Health Care | 2 | 2014 | 5375 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 2001 | 210 | 0.010 |
Why?
|
| Self Report | 1 | 2011 | 3766 | 0.010 |
Why?
|
| Health Promotion | 1 | 2011 | 2209 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1986 | 3102 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2002 | 487 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2708 | 0.010 |
Why?
|
| Public Health | 1 | 2012 | 2682 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1653 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 2488 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2005 | 1249 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1703 | 0.010 |
Why?
|
| HIV Protease Inhibitors | 1 | 2000 | 432 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2007 | 2866 | 0.010 |
Why?
|
| Research | 1 | 2006 | 1981 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1985 | 4177 | 0.010 |
Why?
|
| Rats | 1 | 2014 | 23835 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2017 | 26411 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2005 | 1838 | 0.010 |
Why?
|
| Women's Health | 1 | 2007 | 2078 | 0.010 |
Why?
|
| Lysosomes | 1 | 1983 | 939 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6241 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1983 | 1530 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2005 | 1070 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 5800 | 0.010 |
Why?
|
| Actins | 1 | 1985 | 2059 | 0.010 |
Why?
|
| Skin | 1 | 1971 | 4499 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2906 | 0.010 |
Why?
|
| Heart Atria | 1 | 2003 | 1360 | 0.010 |
Why?
|
| Water Supply | 1 | 1978 | 204 | 0.010 |
Why?
|
| Carcinoma | 2 | 1958 | 2341 | 0.010 |
Why?
|
| Lead | 1 | 1982 | 880 | 0.010 |
Why?
|
| Asbestos | 1 | 1978 | 251 | 0.010 |
Why?
|
| Thrombosis | 1 | 2010 | 2955 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 22355 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 17135 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2139 | 0.010 |
Why?
|
| Estrogens | 1 | 1982 | 1534 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2005 | 1925 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 2948 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2001 | 1209 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8731 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6085 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2008 | 12456 | 0.010 |
Why?
|
| Vaginal Neoplasms | 1 | 1954 | 105 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1976 | 1629 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1982 | 1427 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 4031 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2001 | 1815 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1985 | 975 | 0.010 |
Why?
|
| Menstruation | 1 | 1954 | 310 | 0.010 |
Why?
|
| Pediatrics | 1 | 1988 | 3624 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1958 | 4069 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8562 | 0.010 |
Why?
|
| Postmenopause | 1 | 2001 | 2518 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 36849 | 0.010 |
Why?
|
| Atlantic Islands | 1 | 1971 | 3 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1988 | 4303 | 0.010 |
Why?
|
| Uterus | 1 | 1954 | 661 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1978 | 959 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 5538 | 0.010 |
Why?
|
| HIV-1 | 1 | 2007 | 6963 | 0.010 |
Why?
|
| Thinness | 1 | 1971 | 483 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 2 | 1985 | 2636 | 0.000 |
Why?
|
| Kinetics | 2 | 1985 | 6333 | 0.000 |
Why?
|
| Menstruation Disturbances | 1 | 1988 | 143 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 13020 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2010 | 23631 | 0.000 |
Why?
|
| Endometriosis | 1 | 1954 | 875 | 0.000 |
Why?
|
| Myofibrils | 1 | 1985 | 143 | 0.000 |
Why?
|
| Amoeba | 1 | 1983 | 20 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1976 | 2514 | 0.000 |
Why?
|
| Vesicovaginal Fistula | 1 | 1962 | 10 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1976 | 3627 | 0.000 |
Why?
|
| Ribonucleases | 1 | 1983 | 265 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1983 | 388 | 0.000 |
Why?
|
| Urinary Calculi | 1 | 1962 | 90 | 0.000 |
Why?
|
| Membrane Fusion | 1 | 1983 | 265 | 0.000 |
Why?
|
| Urinary Bladder Diseases | 1 | 1962 | 167 | 0.000 |
Why?
|
| Urination Disorders | 1 | 1962 | 238 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1983 | 573 | 0.000 |
Why?
|
| Hysterectomy | 1 | 1962 | 864 | 0.000 |
Why?
|
| Family Characteristics | 1 | 1982 | 1003 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1982 | 789 | 0.000 |
Why?
|
| Hypotension | 1 | 1961 | 889 | 0.000 |
Why?
|
| Protein Binding | 1 | 1985 | 9343 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1962 | 2044 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1988 | 9198 | 0.000 |
Why?
|